Depression is the most common illness that affects a large number of individuals in all countries. It is believed that decreased levels of neurotransmitters such as serotonin, norepinephrine and dopamine are the main cause of depression. Selective serotonin reuptake inhibitors (SSRIs) and norepinephrine reuptake inhibitors (SNRIs), their mechanism is to increase the amount of neurotransmitters in the CNS. Design, synthesis and molecular docking of novel compounds namely amino acetylenic derivatives of aryloxy as isostere for aryloxypropylamine. The reaction of 7-methoxy-2-naphthol with propargylbromide generated 7-methoxy-2-(prop-2-yn-1-yloxy) naphthalene (ZR-1). ZR-1 was subjected to Mannich reaction yielded the derivatives of aryloxybutynylamines (ZR-2 to ZR-7). The Mp, FTIR, 1 H-NMR, C 13 -NMR, DSC, elemental analysis and HPLC were consistent with the assigned structures. The molecular docking results obtained for aminoacetylenic compounds showed that the new novel 7-methoxy-2-{[4-(piperidine) but-2-yn-1-yl]oxy}-naphthalene (ZR-4) provide effective π overlap with binding sites of SERT protein by ionic, hydrogen bonding and overlap of aryl and cyclic amine moieties with the amino acids of transporter protein, which produce the binding energy (-109,69 kcal/mol) for ZR-4 relative to paroxetine (-114.18 kcal/mol), that may lead to promising drug in the treatment of depression.
INTRODUCTION
Depression is currently conceptualized as a single chronic disease of heterogeneous etiology, which runs from milder forms such as subsyndromal symptomatic depression (SSD), to sever forms of depression including major depression (MD) with melancholic or psychotic features. [1] [2] [3] It is believed that the main biochemical theory of depression is the monoamine hypothesis, first proposed by Schildkraut in 1965, 4 which states that depression is caused by functional deficit of monoamine transmitter's serotonin, norepinephrine, and dopamine in the central nervous system. [5] [6] [7] In addition, changes in glutamatergic neurotransmission may be involved in depression. The human biogenic amine transporters (BATs) represent important drug targets for the medicinal chemist in drug design for treatment diseases such as depression, anxiety, obesity, drug abuse, obsessive compulsive disorder, attention deficit hyperactivity disorder, and schizophrenia. 8, 9 The BATs includes the serotonin (SERT), norepinephrine (NET) transporters, and dopamine (DAT), responsible for re-uptake the neurotransmitters SERT, NET, and DAT respectively and their function by terminating synaptic signaling. [10] [11] [12] [13] [14] [15] Serotonin transporter (SERT) found in the plasma membrane of serotonergic neurons which is responsible for reuptake of the transmitter. The transporter protein acts as carrier of serotonin molecules across the membrane. 16 Serotonin transporter (SERT) transmembrane ion gradients of Na+, Cl -, K+ and an internal negative membrane potential for transport serotonin. 17 This leads to control extracellular levels of serotonin (5hydroxytryptamine, 5HT) in the brain by transporting %5HT into neurons and glial cells fall into two gene families. The main target for drugs used for treatment of depressive disorders is the human SERT (hSERT) 18 , competitive with a variety of naturally occurring amines and drugs. Drugs which are used as antidepressants block the transport of NE and thereby cause an elevation in the synaptic concentrations of NE and potentiation of the activation of postsynaptic receptors. [19] [20] [21] Although details of its mechanism of action remains unknown, NE plays an important role in the CNS. In classifications of antidepressants imipramine, desipramine, amitriptyline, nortriptyline, clomipramine ( Figure 1 ) are widely used, others with different mechanism are used ( Figure 2 ), in spite of the need of other drugs that act more rapidly, produce fewer side effects and are hazardless in overdose. MAOI like phenelzine, tranylcypromine and isocarboxazid are the last new compounds (Figure 3 ), these drugs cause irreversible inhibition of one or both forms of brain MAOI which lead to increase the cytosolic stores of norepinephrine and 5HT in nerve terminals. 2, 22 Investigation the various drugs structures that are selective, non-selective and miscellaneous antidepressant activity. We envision the design and synthesis of aryloxyaminoacetylenic derivatives as isosteres to aryloxypropylamines. as blocking SSRT or SNRT in the brain, through changing the electronic binding side chain, the basic amino acid group is required for ionic or hydrogen bonding to the corresponding amino acids of the SSRI or SNRI protein, the aromatic ring is to provide lipophilic interaction and π-overlap with aromatic amino acids of SERT or SSRT or both. The newly synthesized compounds may exert drug-drug interaction due to inhibition of cytochrome P450. The docking results verified a possible potent activity of these new novel compounds. 
MATERIALS AND METHODS

Instrumental
Melting points were determined by using a Gallenkamp Melting Point Apparatus and Differential scanning calorimetry (DSC) thermogram measurement was carried out by using the DSC 1 STARE system v.110x (METTLER TOLEDO). Infrared Spectra (IR) were recorded using WQF-A 520 FT-IR Spectrophotometer, H 1 and C 13 NMR was acquired with the aid of BRUKER 500 MHZ-AvanceIII Spectrophotometer and DMSO-d 6 as solvent, and TMS as standard (University of Jordan). HPLC (FINNIGAN SURVEYOR) was used, the detector (UV-VIS plus Detector), the pump (LC Pump Plus) and the autosampler (Autosampler Plus). Elemental analysis was indicated by EuroEA 3000 Elemental Analyzer (Euro Vector, University of Hashemite). ChemSKetch was used in the drawing of our schemes.
Molecular docking A validated homology model of SERT protein by
Wang's group 23 was used in our docking study. Chargers were assigned to all proteins atoms using Kollman united atom model in the Autodock Tool program [24] [25] then the active sites of SERT was defined by a known inhibitor. Agrid box of a 50 x 42 x 60 size was created, with a grid spacing of 0.375 Å using autogrid modules. Ligand 3D structures were built using the maestro program 26 , and were then minimized using the OPLS force field 27 . Gasteiger-Marsili model 28 was used to give atomic charges for all ligands whose tertiary amine groups were assigned as protonated. Subsequently, ligands were docked into previously identified active site using the Autodock software (version 4.2) [29] [30] , where Lamarckian Genetic Algorithm 29 was employed for the conformational sampling process. Poses generated by docking were then rated by the Autodock scoring function with estimates binding free energy via calculated van der Waals, hydrogen bond, electrostatic interactions, and the ligand internal energy for each ligandprotein complex.
Synthesis 7-methoxy-2-(prop-2-yn-1-yloxy)-naphthalene (ZR-1)
7-methoxy 2-naphthol (3.485 g, 0.020 mol), potassium carbonate anhydrous (2.75 g, 0.020 mol) and 30-40 ml acetonitrile were heated and stirred under reflux until temperature becomes 75 C, then the propargyl bromide (4.76 g, 0.040 mol) was added dropwise. The mixture was stirred under reflux for hour, filtered and reduced under reduced pressure. The product was extracted with 1:1 chloroform and distilled water. The chloroform layers were collected and concentrated by reduced pressure. The brown powder C 12 
7-methoxy-2-{[4-(t-amino-1-yl) but-2-yn-1-yl] oxy}-naphthalene by Mannich reaction (ZR-2 to ZR-7)
7-methoxy-2-(prop-2-yn-1-yloxy) naphthalene (ZR-1) (2.12 g, 0.01 mole), Paraformaldehyde (0.5 g, 0.015 mole), 0.01 mole cyclic amine and a catalytic amount of cuprous chloride (0.03g) in 30 ml dioxane was added, stirred for three hours under reflux at 70-75 o C. The mixture concentrated under reduced pressure, filtered and evaporated. The final products were ZR-2 to ZR-7 (Figure 3) .
7-methoxy-2-{[4-(2-methylPiperidine) but-2-yn-1yl] oxy}-naphthalene (ZR-2)
ZR-2 was prepared according to the same procedure described for the synthesis of ZR-2 to ZR-7. 
7-methoxy-2-{[4-(2, 6-dimethyl Piperidine) but-2yn-1-yl] oxy}-naphthalene (ZR-3)
ZR-3 was synthesized using the same procedure described for the synthesis of ZR-2 to ZR-7. Yield 50.45%, m.p was (97C-102C), retention time using UV-HPLC (2.335 min). FT-IR spectra (KBr cm -1 ) δ: 3064 (Ar C-H stretching), 2912, 2822 (alkanes C-H stretching), 1621, 1511, 1442 (Ar C=C stretching), 839, 790 (Ar C-H bending), 1022 (aryl, alkyl C-O stretching), 1201, 1115 (3 o amines N-C stretching). 1 
7-methoxy-2-{[4-(Piperidine) but-2-yn-1-yl] oxy}naphthalene (ZR-4)
ZR-4 was synthesized using the same procedure described for the synthesis of ZR-2 to ZR-7. Yield 38.83%, m.p was (38C-44C), retention time using UV-HPLC was (2.235 min). FT-IR (KBr cm -1 ) δ: 
7-methoxy-2-{[4-(Pyrimidine) but-2-yn-1-yl] oxy}naphthalene (ZR-5)
ZR-5 was synthesized using the same procedure described for the synthesis ZR-2 to ZR-7. Yield 57.63%, retention time using UV-HPLC was (2. 
7-methoxy-2-{[4-(N-methylpiperazine) but-2-yn-1yl] oxy}-naphthalene (ZR-6)
ZR-6 was synthesized using the same procedure described for the synthesis of ZR-2 to ZR-7. Yield 
7-methoxy-2-{[4-(hexamethyleneimine) but-2-yn-1-yl] oxy}-naphthalene (ZR-7)
ZR-7 was synthesized using the same procedure described for the synthesis ZR-2 to ZR-7. Yield 
RESULTS AND DISCUSSION
Chemistry
Compounds (ZR-2 to ZR-7) were prepared from ZR-1 as illustrated in figure 3. ZR-1 was synthesized through the formation of phenolate anion that displaces the bromine on β-carbon of propargyl bromide to afforded 7-methoxy-2-(prop-2-oxy)-naphthalene (ZR-1). ZR-1 was subjected to Mannich reaction that involves first condensation of formaldehyde with the cyclic amine, followed by loss of water and the formation of Schiff base. The attack of the acetylenic anion of the methoxy-2-(prop-2-yn-1-yloxy) on the carbon double bond of the imine (Schiff base) to generate the desired compounds (ZR-2 to ZR-7).
Molecular Docking
The design compounds as SERT blockers are based on isoteric concept of the important criteria needed to overlap effectively with SERT protein to induce reuptake inhibition activity. These criteria are A-The basic cyclic amine is required for ionic and hydrogen interactions. B-The unique acetylenic moiety required to accommodate for electronic interaction with amino acid of the protein transporter. C-The oxy group for hydrogen bonding. D-2-butyne to provide the appropriate distance between the basic cyclic amine and the oxy group of naphthol moiety. E-The naphthol ring generates appropriate πoverlap with SERT to strengthen reuptake inhibitors activity.
Studies of SERT protein binding sites illustrate the importance of hydrogen bonding, electrostatic interaction and hydrophobic interactions, to inhibit the action of SERT. In a comparison between the docking binding modes of paroxetine and ZR-4 compound ( figure 4 a, 
Figure 3 Synthesis of 7-methoxy-2-{[4-(amino-1-yl) but-2-yn-1-yl] oxy}-naphthalene (ZR-2 to ZR-7)
Figure 4a
Shows the binding mode demonstrated by ZR-4 (the blue stick) in the active site of SERT (golden), the interaction ligands were expressed by dashed lines while the hydrogen bindings were in (gray), ionic interactions were (green) and pi -overlaps were (purple).
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Figure 4b Shows the binding mode demonstrated by paroxetine (brown) in the active site of SERT (golden), the interaction ligands were expressed by dashed lines while the hydrogen bonding (gray), the ionic bonding (green), and the pi-overlap (purple).
CONCLUSION
The synthesis and characterization of the new series of 7-methoxy-2-{[4-(t, amino-1-yl) but-2-yn-1-yl] oxyl}naphthalene (ZR-2 to ZR-7) were accomplished. Docking of the new amino acetylenic-7-methoxynaphthalene compounds showed promising approach for synthesis of compounds which may be of potential use in treatment of diseases such as depression, ADHD, bipolar depression. Obesity.
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